Core Viewpoint - Zhejiang Kehui Medical Devices Co., Ltd. is progressing with its initial public offering (IPO) guidance, having signed a counseling agreement with Zheshang Securities in July 2022, with the thirteenth phase of guidance scheduled from July 1, 2025, to September 30, 2025 [2] Company Overview - Founded in 1994, Kehui Medical specializes in the research and production of orthopedic implant materials and is recognized as a national "specialized, refined, and innovative" small giant enterprise [2] - The company holds 204 various medical device product registration certificates or filing documents, covering major segments in orthopedic medical devices, including trauma, spine, vertebroplasty systems, joints, and sports medicine [2] Capital Changes - In March of this year, Kehui Medical underwent a change in registered capital, reducing it from 61.506 million yuan to 60.30 million yuan, a decrease of 1.96% [2] - Changes in the supervisory board included the exit of supervisors Dai Minghua and Miao Shunhao, with new supervisors Zhang Huadong and Li Xianggui appointed, and Chen Jianrong taking over as the new chairman of the supervisory board [2]
科惠医疗拟上市：注册资金减少2%至6030万元，3名监事更换
Sou Hu Cai Jing·2025-10-24 02:04